European Union OKs Truxima as Biosimilar to Rituximab to Treat Lymphoma, Other Diseases
News
The European Union has approved Celltrion Healthcare’s biosimilar Truxima to treat the same conditions as rituximab, the therapy on which Truxima is based. The European Commission’s sign-off means Truxima (CT-P10) can ... Read more